Doctor Mark Kowala

A PhD scientist with expertise in Cardiovascular Disease, Drug Discovery, Translational Medicine, Early Clinical Development. Proficient in heart failure, cardiomyopathy, dyslipidemia, atherosclerosis, and hypertension. Discovered and developed small molecule, peptide, monoclonal antibody therapeutics, several of which are in clinical development or FDA approved. Has 30 years of experience in the Pharmaceutical Industry as a scientist and as a leader of scientists. Hobbies include travel to historic locations and hiking.